Navigation Links
Scientists unveil structure of molecular target of many drugs
Date:10/29/2007

More than 40 years after beta blockers were first used clinically, scientists can finally get a detailed, three-dimensional look at the drugs molecular targetthe beta2-adrenergic receptor. This receptor hails from a family of proteins called G protein-coupled receptors (GPCRs) that control critical bodily functions, several of our senses, and the action of about half of todays pharmaceuticals. Because this is the first known structure of a human GPCR, the work promises not only to speed the discovery of new and improved drugs, but also to broaden our understanding of human health and disease.

Published online in the October 25 issue of Science Express, the research was supported by two major initiatives of the National Institutes of Healththe NIH Roadmap for Medical Research and the Protein Structure Initiative (PSI), which is led by the National Institute of General Medical Sciences. Additional funding came from a Javits Neuroscience Award from the National Institute of Neurological Disorders and Stroke.

To solve the new structure, the researchers overcame daunting scientific obstacles. Many of these difficulties arise because GPCRs are membrane proteinssome of the trickiest molecules to capture in three-dimensional detail because they resist forming crystals, which are needed for structure determination.

Because of their role in so many medically important processes and the great challenges they present for detailed study, membrane proteins have been one focus of the NIH Roadmap, said NIH Director Elias A. Zerhouni, M.D. The determination of this structure is an exciting example of the rewards from the Roadmap investment.

Scientists across the country have tried for years to obtain detailed images of GPCR proteins. Theyve succeeded only once before, in 2000, when a research group determined the structure of a visual pigment in cow eyes. Part of the job was easier then, because the pigment protein is abundant. One of t
'/>"/>

Contact: Emily Carlson
carlsone@nigms.nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences  
Source:Eurekalert

Page: 1 2

Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
3. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
4. UAB scientists discover the origin of a mysterious physical force
5. Fox Chase Cancer Center scientists identify immune-system mutation
6. Scientists Replicate Hepatitis C Virus in Laboratory
7. Scientists detect probable genetic cause of some Parkinsons disease cases
8. Scientists find missing enzyme for tuberculosis iron scavenging pathway
9. Scientists seek answers on what activates deadly anthrax spores
10. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
11. Scientists collaborate to assess health of global environment

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists unveil structure of molecular target of many drugs
Scientists unveil structure of molecular target of many drugs
(Date:11/3/2009)...en are as much as 28 percent less likely to become...ng to research that earned a Michigan State Univer...by Barbara Luke, a researcher in the MSU College o...ology and Reproductive Biology, focused on data of...echnology. , Luke,s findings, which also can be ...
(Date:11/3/2009)...y Samueli School of Engineering and Applied Scienc...ed in the laboratory the enzyme responsible for pr...lovastatin. , The research, published Oct. 23...to the development of other compounds with similar...esizing enzyme is one of the most interesting but ...
(Date:11/3/2009)...of Illinois at Chicago have received $1 million fr... study the relationship between "fat taxes" and fo...funding for the two-year project was made availabl...ct of 2009. , The study will link state tax rate...gar- and fat-laden foods and beverages (soda, cand...
Breaking Biology News(10 mins):MSU researcher: Obesity significantly cuts odds of successful pregnancy 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2UIC receives $1 million grant to study 'fat taxes,' diet, obesity 2Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 1Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 2Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 3Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 4Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 5Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 6Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 7Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 8Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 9Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 10Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 11Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 12Phytomedics Inc Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F 4868 1Phytomedics Inc Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F 4868 2Phytomedics Inc Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F 4868 3Valley Riding Will Host Horse Festival in the Cleveland Metroparks on Sunday August 23 from 11 AM to 4 PM 54833 1Valley Riding Will Host Horse Festival in the Cleveland Metroparks on Sunday August 23 from 11 AM to 4 PM 54833 2
...e about how the brain assigns cells to participate...versity of Toronto team has discovered that a prot...ing a role in memory formation. The April 20 edit... a new approach for preserving memory in people su... , "Making a memory is not a conscious act," expla...
...al nervous system (CNS) in animal evolution has pu...ts and worms evolved from the same ancestor, but t...volved only after their lineages had split during ... Biology Laboratory (EMBL) in Heidelberg now revea...uch older than expected. The study, which is publi...
...tel, cancer is a metaphorical example of the perfe...regnant finch that landed on a deserted island in ...n the human body has to undergo many mutations thr...vader of different organs in the body. But once it...fferent ecological niches, cancer is tough to get ...
Other Biology News:UCLA/Toronto researchers unlock key to memory storage in brain 2The origin of the brain lies in a worm 2New bird, bat species revealed by extensive DNA barcode studies 2
(Date:11/6/2009)...alif., Nov. 6 Intarcia Therapeutic...TCA 650 (DUROS® continuous delivery of exenat...at the Ninth Annual Diabetes Technology Meeting in...om.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, ... ITCA 650 Lowers Plasma Glucose, HbA1c and Reduces...
(Date:11/5/2009)..., N.J., Nov. 5 DSM Pharmaceutical ...cturing alliance with Galenix, Saint Jean D,Illac,...l scale manufacturing partner for Galenix commerci...ix will collaborate on business development opport...ogies, based on the strength of Galenix in drug pr...
(Date:11/5/2009)...N.Y., Nov. 5 BioSpecific...ceutical company developing first-in-class collage... results for the third quarter ended September 30,...ptember of this year, the FDA,s Arthritis Advisory...2-0, the approval of XIAFLEX(TM) for the treatment...
(Date:11/5/2009)...xas, Nov. 5 SpineSmith Partners ha...to co-develop a unique scaffold that mimics the st...luation of several commercial products by SpineSmi...any believes the GenOsteo scaffold represents a si... unique and ideal environment for the delivery of ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
... EDMONTON, Sept. 3 /PRNewswire-FirstCall/ - BioMS... treatment of multiple sclerosis (MS), announced,t...bid. Under the bid,which will be conducted pursuan..."), the Company may purchase up to 1,000,000 of it...esenting approximately 1.1% of the,Company,s issue...
.... (Nasdaq:,PLXS) announced today that it intends t...tered into an agreement to lease approximately 106...ted in Hangzhou. The new,facility will allow Plexu...ecision centers in the greater Shanghai area, and ...tal cost value proposition. This location,will be ...
...ity of Manchester who discovered the world,s thinn...work. , Professor Andre Geim FRS and Dr Kostya No...ology have been awarded the prestigious Europhysic...ubsequent work to reveal its remarkable electronic... of carbon atoms resembling chicken wire. This inc...
Other Biology Technology:BioMS Medical announces its intention to renew a normal course issuer bid 2BioMS Medical announces its intention to renew a normal course issuer bid 3Plexus Announces Expansion in Hangzhou, China 2Plexus Announces Expansion in Hangzhou, China 3Graphene pioneers follow in Nobel footsteps 2
Mouse Anti-Simian Virus 5 Monoclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-Simian Virus 5 Monoclonal Antibody, FITC Conjugated from AbD Serotec
Mouse Anti-Human MBP aa67-74 Monoclonal Antibody, Unconjugated from AbD Serotec
...cDNA Purification Kit is designed to purify double...ions such as cDNA synthesis and PCR. The process i...o 3 g can be efficiently purified and concentrated...1) DNA is bound to the Microfilter Cartridge in th...
Biology Products: